Page last updated: 2024-11-02

pentamidine and Candidiasis, Oral

pentamidine has been researched along with Candidiasis, Oral in 2 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Candidiasis, Oral: Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nolan, A1
Lamey, PJ1
MacFarlane, TW1
Aitchison, TC1
Shaw, J1
Sirel, JY1

Trials

1 trial available for pentamidine and Candidiasis, Oral

ArticleYear
The effect of nebulised pentamidine on the concentration of intra-oral Candida albicans in HIV-infected patients.
    Journal of medical microbiology, 1994, Volume: 41, Issue:2

    Topics: Administration, Inhalation; Adult; Aerosols; Candida albicans; Candidiasis, Oral; Carrier State; Fem

1994

Other Studies

1 other study available for pentamidine and Candidiasis, Oral

ArticleYear
Drugs for AIDS and associated infections.
    The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga

1995